Bosch Healthcare Solutions GmbH
Vivalytic Bacterial Meningitis by Bosch: PCR rapid test for medical emergencies
mehr
Storys zum Thema Krankheit
- Sprache:
- Medien:
- Zeitraum:
- Zeitraum:Gesamt
RHEACELL receives EMA approval for allo-APZ2-CVU Phase 3 trial in chronic venous ulcers
mehrMaria-Elena Torres-Padilla Honored With the Leibniz Prize 2025
mehrGEA launches Body Condition Scoring for cows
Ein DokumentmehrInceptor Regulates Insulin Homeostasis: A New Approach for Diabetes Therapies
mehrLast Call for canSERV Third Open Call Funding
Ein Dokumentmehr
Event Announcement: VIROFIGHT Hybrid Symposium
Ein DokumentmehrRHEACELL announces FDA approval for Phase 3 study in refractory, non-curable CVU
mehrLaunch of canSERV Call for Service Provision – "Training the Next Generation of Cancer Researchers"
Ein Dokumentmehr- 2
Fundació Puigvert validates a new tool capable of selecting the most suitable antibiotic for uncomplicated urinary tract infections within 45 minutes.
Ein Dokumentmehr - 2
Record financing rounds at the Munich biotech hub
Ein Dokumentmehr Bosch Healthcare Solutions GmbH
Near-patient PCR rapid test for whooping cough for Vivalytic by Bosch now available / World's first fully automated PCR test for detection of B. pertussis, B. parapertussis, B. holmesii
mehr
canSERV relaunches Open Call for Service Provision
Ein DokumentmehrPress release: STADA continues strong growth journey in the first half of 2024
Ein DokumentmehrResearch Success in Rare Disease / RHEACELL receives positive signal for accelerated stem cell development program in rare ‚Butterfly Disease‘
mehrLeipzig Tourismus und Marketing GmbH
5Pioneering Heart Surgery and Medical Congresses in Leipzig
Ein DokumentmehrTen benefits of a daily intake of citrus fruits during winter season
mehrThe easiest fruit celebrates its 'Apple Day'
mehr
- 2
Press release : People with Parkinson’s experience variations in effects of oral medicines, but lack advice, international survey reveals
Ein Dokumentmehr RHEACELL announces “First Patient In”: EB-Haus in Salzburg, Austria starts pivotal study for stem cell therapy for severe forms of Epidermolysis bullosa that is longed for by those affected
mehr- 5
Press Release - hubergroup India expands its support for rural healthcare
Ein Dokumentmehr The world's first Extended Isolated Stopflow Limb Infusion (EISLI) to treat osteosarcoma results in complete remission
mehrInnovation and Start-up Center Biotechnology (IZB) welcomes Invitris
Ein DokumentmehrBreakthrough - EUR 50 million investment for start-up BrainRepair UG / Pivotal trial on stem cell treatment for brain damage in newborns fully funded
mehr
Flu tests from R-Biopharm also detect new virus variants
mehrStem cell therapy for “Butterfly disease” / RHEACELL receives ‘Partners in Progress Award’ from debra of America for Epidermolysis Bullosa research
mehrKlinik für Prostata-Therapie Heidelberg
Focal therapy for prostate cancer: Reliable diagnosis leads to gentle treatment
mehrR-Biopharm starts commercialization of the fully automated RIDA®UNITY system for real-time PCR in molecular diagnostic laboratories
mehrR-Biopharm announces test to detect monkeypox virus
mehrInnovation and Start-Up Center for Biotechnology (IZB) welcomes new start-up Origin.Bio
Ein Dokumentmehr
Vorherige1234Nächste